Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 104kWORD 18k
24 January 2018
Question for written answer E-000379-18
to the Commission
Rule 130
Annie Schreijer-Pierik (PPE)

 Subject:  European strategic approach to pollution of water by pharmaceutical substances
 Answer in writing 

For several years now, Member States, citizens, producers and other stakeholders have been awaiting the European strategic approach to pollution of water by pharmaceutical substances. In the Dutch delta, the first steps under the chain approach have been taken by the water industry, producers and public authorities, but the problem is of a cross-border nature.

1. When will the Commission present the strategic approach to pollution of water by pharmaceutical substances, as required under Directive 2013/39/EU (Priority Substances Directive)?

2. How will the Commission take this strategy into account in the evaluation of Directive 2000/60/EC and Directive 2013/39/EU which is planned in 2018-2019?

3. Can the Commission indicate what drug residues in water cause problems in treating drinking water, to what extent it takes account of Article 7(3) of the Water Framework Directive in this context, and to what extent it intends to incorporate into the strategic approach Article 6 of Directive 92/43/EEC, Articles 8 and 10 of Directive 2000/60/EC and the EU’s ‘European One Health Action Plan against Antimicrobial Resistance’ (mainly concerning antibiotic-resistant bacteria)?

Original language of question: NL 
Last updated: 7 February 2018Legal notice